AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SOFOSBUVIR & VELPATASVIR
18 registrations across 7 African markets— 10 active
Markets with SOFOSBUVIR & VELPATASVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MyHep ALL Tablets Tablet | 🇳🇬Nigeria | Healthline Limited | active | Jan 2030 |
| Sofosbuvir, Velpatasvir Tablets, Debossed With "Gsi" On One Side And "7916" On The Other Side. | 🇷🇼Rwanda | GILEAD SCIENCES INC | active | Aug 2026 |
| Epclusa Tablets 400/100 mg Tablet | 🇳🇬Nigeria | Phillips Pharmaceuticals (Nigeria) Limited | active | Nov 2025 |
| MYHEP-ALL 400/100MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Mar 2025 |
| SOVEL 400MG/100MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | THE SEARLE COMPANY LIMITED | expired | Oct 2024 |
| VELSO 100MG/40MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | GENIX PHARMA PVT LTD | expired | Feb 2024 |
| SOFOSBUVIR+VELPATASVIR 400MG/100MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | MYLAN LABORATORIES LTD | expired | Feb 2024 |
| VELPANAT 400-100MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | AMANYS PHARMA PRIVATE LIMITED | expired | Jan 2024 |
| VELSOF 400-100MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | HETERO LABS LIMITED | expired | Jan 2023 |
| MYHEP ALL Comprimé pelliculé / 400mg/100mg | 🇹🇳Tunisia | MYLAN LABORATORIES LIMITED. | expired | Sept 2022 |
| SOFO-VEL 400MG/100MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PRIVATE) LIMITED | expired | Jan 2021 |
| EPCLUSA COMPRIME PELLICULE / 400mg/100mg | 🇸🇳Senegal | GILEAD | active | — |
| EPCLUSA 100 mg /400 mg | 🇸🇳Senegal | — | active | — |
| Sofosbuvir/Velpatasvir Tablet, Film-coated 400mg/100mg Tablet, Film-coated | 🌍WW | Mylan Laboratories Ltd. | active | — |
| EPCLUSA comprimé / 100 mg /400 mg | 🇸🇳Senegal | GILEAD SCIENCES | active | — |
| EPCLUSA COMPRIME PELLICULE / 400mg/100mg | 🇸🇳Senegal | GILEAD | active | — |
| Sofosbuvir/Velpatasvir Tablet, Film-coated 400mg/100mg Tablet, Film-coated | 🌍WW | Gilead Sciences Ireland UC | active | — |
| SOVEL comprimé / 400 mg /100 mg | 🇸🇳Senegal | SEARLE COMPANY LIMITED | active | — |
SOFOSBUVIR & VELPATASVIR in Africa — Regulatory Overview
SOFOSBUVIR & VELPATASVIR is registered across 7 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal, Nigeria, WW and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 10 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.